When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NWBO - Denovo Biopharma's enzastaurin Fast Track'd for brain tumor
Northwest Biotherapeutics Inc.
The FDA designates privately held Denovo Biopharma's lead candidate DB102 (enzastaurin) for Fast Track review for the treatment of newly diagnosed glioblastoma, an aggressive cancer of the brain or spinal cord.
More news on: Eli Lilly and Company, MediciNova, Inc., ZIOPHARM Oncology, Inc., Healthcare stocks news,